| Dr Michael James Banyasz, MD | |
|
350 N Grandview Ave, Dubuque, IA 52001-6388 | |
| (563) 582-1881 | |
| Not Available |
| Full Name | Dr Michael James Banyasz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 350 N Grandview Ave, Dubuque, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619160322 | NPI | - | NPPES |
| 35.091111 | Other | OH | STATE MEDICAL BOARD OF OHIO LICENSE |
| 386672503 | Medicaid | TX | |
| 386672501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | R6741 (Texas) | Primary |
| Entity Name | University Emergency Specialists Of Bedford Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760434781 PECOS PAC ID: 2466357801 Enrollment ID: O20031126000765 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | 4m Emergency Systems Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932152584 PECOS PAC ID: 7719882182 Enrollment ID: O20031201000099 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | Mahoning Valley Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003869652 PECOS PAC ID: 5698758993 Enrollment ID: O20040609000114 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | Ues Geauga, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841242997 PECOS PAC ID: 6406876002 Enrollment ID: O20051128000779 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | Mves Boardman Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205888237 PECOS PAC ID: 4688694722 Enrollment ID: O20051202000794 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | University Hospitals Ahuja Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609189604 PECOS PAC ID: 5496935538 Enrollment ID: O20120424000026 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | University Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033454483 PECOS PAC ID: 4587807854 Enrollment ID: O20130905000711 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | Ues Geneva Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689919029 PECOS PAC ID: 4789827064 Enrollment ID: O20130905000813 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Entity Name | Magis Emergency Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801287511 PECOS PAC ID: 2769700392 Enrollment ID: O20150410002555 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael James Banyasz, MD 350 N Grandview Ave, Dubuque, IA 52001-6388 Ph: (563) 582-1881 | Dr Michael James Banyasz, MD 350 N Grandview Ave, Dubuque, IA 52001-6388 Ph: (563) 582-1881 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.
Overweight and obese individuals can achieve a decade's worth of important health benefits by losing just 20 pounds, even if they regain the weight later that decade, according to research presented at the American Psychological Association's 120th Annual Convention. With a focus on psychology's role in overcoming the national obesity epidemic, the session also examined research that indicates foods high in sugar and fat could have addictive properties.
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
› Verified 7 days ago
Michael Chandler Severson, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Mercy Dr, Dubuque, IA 52001 Phone: 563-589-9667 | |
Dr. Timothy L Bowers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-582-1881 | |
Neal Sauerberg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-582-1881 | |
Dr. Theodore H Gifford, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-582-1881 | |
Dr. Sean Matthew Wetjen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Mercy Dr, Dubuque, IA 52001 Phone: 202-491-1958 | |
Dr. Mark J Singsank, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Mercy Dr, Dubuque, IA 52001 Phone: 563-589-8000 | |
Staci Elaine Mckeon, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3455 Fax: 563-584-3177 |